Literature DB >> 29235540

Characteristic dysmorphic features in congenital disorders of glycosylation type IIb.

Yoon-Myung Kim1, Go Hun Seo1, Euiseok Jung1, Ja-Hyun Jang2,3, Sook Za Kim4, Beom Hee Lee5.   

Abstract

Over 100 types of congenital disorders of glycosylation (CDG) have been reported and the number is rapidly increasing. However, each type is very rare and is problematic to diagnose. Mannosyl-oligosaccharide glucosidase (MOGS)-CDG (CDG type IIb) is an extremely rare CDG that has only been reported in three patients from two unrelated families. Using targeted exome sequencing, we identified another patient affected by this condition. This patient had increased serum trisialotransferrin levels. Importantly, a review of the features of all four patients revealed the recognizable clinical hallmarks of MOGS-CDG. The distinct dysmorphic features of this condition include long eyelashes, retrognathia, hirsutism, clenched overlapped fingers, hypoventilation, hepatomegaly, generalized edema, and immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29235540     DOI: 10.1038/s10038-017-0386-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  12 in total

1.  B4GALT1-congenital disorders of glycosylation presents as a non-neurologic glycosylation disorder with hepatointestinal involvement.

Authors:  Maïlys Guillard; Eva Morava; Jorg de Ruijter; Tony Roscioli; Johann Penzien; Lambert van den Heuvel; Michel A Willemsen; Arjan de Brouwer; Olaf A Bodamer; Ron A Wevers; Dirk J Lefeber
Journal:  J Pediatr       Date:  2011-09-13       Impact factor: 4.406

2.  Thyroid function in PMM2-CDG: diagnostic approach and proposed management.

Authors:  Miski Mohamed; Miranda Theodore; Hedi Claahsen-van der Grinten; Antonius E van Herwaarden; Karin Huijben; Lotte van Dongen; Dorus Kouwenberg; Dirk J Lefeber; Ron A Wevers; Eva Morava
Journal:  Mol Genet Metab       Date:  2012-02-13       Impact factor: 4.797

Review 3.  What is new in CDG?

Authors:  Jaak Jaeken; Romain Péanne
Journal:  J Inherit Metab Dis       Date:  2017-05-08       Impact factor: 4.982

4.  Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

Authors:  Mohammed A Sadat; Susan Moir; Tae-Wook Chun; Paolo Lusso; Gerardo Kaplan; Lynne Wolfe; Matthew J Memoli; Miao He; Hugo Vega; Leo J Y Kim; Yan Huang; Nadia Hussein; Elma Nievas; Raquel Mitchell; Mary Garofalo; Aaron Louie; Derek C Ireland; Claire Grunes; Raffaello Cimbro; Vyomesh Patel; Genevieve Holzapfel; Daniel Salahuddin; Tyler Bristol; David Adams; Beatriz E Marciano; Madhuri Hegde; Yuxing Li; Katherine R Calvo; Jennifer Stoddard; J Shawn Justement; Jerome Jacques; Debra A Long Priel; Danielle Murray; Peter Sun; Douglas B Kuhns; Cornelius F Boerkoel; John A Chiorini; Giovanni Di Pasquale; Daniela Verthelyi; Sergio D Rosenzweig
Journal:  N Engl J Med       Date:  2014-04-09       Impact factor: 91.245

5.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency.

Authors:  G J Gerwig; E Bause; L K Nuytinck; J F Vliegenthart; W Breuer; J P Kamerling; M F Espeel; J J Martin; N W Chan; G A Dacremont
Journal:  Am J Hum Genet       Date:  2000-04-28       Impact factor: 11.025

6.  Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation.

Authors:  Megan S Kane; Mariska Davids; Christopher Adams; Lynne A Wolfe; Helen W Cheung; Andrea Gropman; Yan Huang; Bobby G Ng; Hudson H Freeze; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Am J Hum Genet       Date:  2016-01-21       Impact factor: 11.025

7.  Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I.

Authors:  P E Macchia; H H Harrison; N H Scherberg; T Sunthornthepfvarakul; J Jaeken; S Refetoff
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

8.  Transferrin variants: pitfalls in the diagnostics of Congenital disorders of glycosylation.

Authors:  Andrea Zühlsdorf; Julien Heinrich Park; Yoshinao Wada; Stephan Rust; Janine Reunert; Ingrid DuChesne; Marianne Grüneberg; Thorsten Marquardt
Journal:  Clin Biochem       Date:  2014-10-08       Impact factor: 3.281

Review 9.  Biological roles of glycans.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2016-08-24       Impact factor: 4.313

Review 10.  Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation.

Authors:  Monique Van Scherpenzeel; Esther Willems; Dirk J Lefeber
Journal:  Glycoconj J       Date:  2016-01-07       Impact factor: 2.916

View more
  5 in total

1.  Defective mucin-type glycosylation on α-dystroglycan in COG-deficient cells increases its susceptibility to bacterial proteases.

Authors:  Seok-Ho Yu; Peng Zhao; Pradeep K Prabhakar; Tiantian Sun; Aaron Beedle; Geert-Jan Boons; Kelley W Moremen; Lance Wells; Richard Steet
Journal:  J Biol Chem       Date:  2018-07-26       Impact factor: 5.157

2.  Identification and characterization of novel mutations in MOGS in a Chinese patient with infantile spams.

Authors:  Xuehua Peng; Sukun Luo; Yufeng Huang; Li Tan; Jianbo Shao; Xuelian He
Journal:  Neurogenetics       Date:  2020-01-10       Impact factor: 2.660

3.  Updated clinical and glycomic features of mannosyl-oligosaccharide glucosidase deficiency: Two case reports.

Authors:  Kuerbanjiang Abuduxikuer; Lei Wang; Lin Zou; Cui-Yan Cao; Long Yu; Hong-Mei Guo; Xin-Miao Liang; Jian-She Wang; Li Chen
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

4.  Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review.

Authors:  Rossella Colantuono; Elisa D'Acunto; Daniela Melis; Pietro Vajro; Hudson H Freeze; Claudia Mandato
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-10-01       Impact factor: 3.288

Review 5.  Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations.

Authors:  Hans-Hartmut Peter; Hans D Ochs; Charlotte Cunningham-Rundles; Donald C Vinh; Peter Kiessling; Bernhard Greve; Stephen Jolles
Journal:  J Allergy Clin Immunol       Date:  2020-09       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.